Cosma Stefano, Petruzzelli Paolo, Danese Saverio, Benedetto Chiara
Stefano Cosma, Chiara Benedetto, Department of Surgical Sciences, University of Torino, 10126 Torino, Italy.
World J Gastrointest Endosc. 2017 May 16;9(5):211-219. doi: 10.4253/wjge.v9.i5.211.
To compare our developed nerve preserving technique with the non-nerve preserving one in terms of bowel symptoms.
Patients affected by symptomatic apical prolapse, admitted to our department and treated by nerve preserving laparoscopic sacropexy (LSP) between October, 2010 and April, 2013 (Group A or "interventional group") were compared to those treated with the standard LSP, between September, 2007 and December, 2009 (Group B or "control group"). Functional and anatomical data were recorded prospectively at the first clinical review, at 1, 6 mo, and every postsurgical year. Questionnaires were filled in by the patients at each follow-up clinical evaluation.
Forty-three women were enrolled, 25/43 were treated by our nerve preserving technique and 18/43 by the standard one. The data from the interventional group were collected at a similar follow-up (> 18 mo) as those collected for the control group. No cases of bowel dysfunction were observed in group A against 4 cases in group B ( = 0.02). Obstructed defecation syndrome (ODS) was highlighted by an increase in specific questionnaires scores and documented by the anorectal manometry. There were no cases of constipation in the two groups. No major intraoperative complications were reported for our technique and it took no longer than the standard procedure. Apical recurrence and late complications were comparable in the two groups.
Our nerve preserving technique seems superior in terms of prevention of bowel dysfunction compared to the standard one and had no major intraoperative complications.
在肠道症状方面,将我们研发的保留神经技术与非保留神经技术进行比较。
将2010年10月至2013年4月期间因症状性顶端脱垂入住我科并接受保留神经腹腔镜骶骨固定术(LSP)治疗的患者(A组或“干预组”)与2007年9月至2009年12月期间接受标准LSP治疗的患者(B组或“对照组”)进行比较。在首次临床复查、术后1个月、6个月以及术后每年前瞻性记录功能和解剖学数据。在每次随访临床评估时,患者填写问卷。
共纳入43名女性,其中25/43接受了我们的保留神经技术治疗,18/43接受了标准技术治疗。干预组的数据收集随访时间(>18个月)与对照组相似。A组未观察到肠道功能障碍病例,而B组有4例(P = 0.02)。通过特定问卷评分增加突出显示了排便梗阻综合征(ODS),并通过肛门直肠测压记录。两组均无便秘病例。我们的技术未报告重大术中并发症,且手术时间不超过标准手术。两组顶端复发和晚期并发症相当。
与标准技术相比,我们的保留神经技术在预防肠道功能障碍方面似乎更具优势,且无重大术中并发症。